We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Peptide-Based Wound Dressing Kills Bacteria Efficiently

By HospiMedica International staff writers
Posted on 19 Aug 2020
An advanced wound dressing that contains cellulose membranes with bifunctional peptides shows potent antimicrobial activity, according to a new study.

Developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa; Dübendorf, Switzerland), the dressings, made from plant‐derived cellulose fibers with a diameter of less than one micrometer, are electrospun into a delicate multi-layered, three-dimensional (3D) fabric that also contains the polymer polyurethane. More...
The cellulose membrane contains a bifunctional peptide which combines an antimicrobial peptide (AMP) and a cellulose binding peptide (CBP), with tight control over peptide concentrations.

The fiber scaffold of the fibroblast cytocompatible membranes are saturated with such bifunctional peptides, affecting bacteria via multiple modes of action, reducing evolutionary pressure selecting for antibiotic resistance. In cell cultures, the dressing exhibited a log4 reduction against Staphylococcus aureus, and a log1 reduction against Pseudomonas aeruginosa. In addition, using the cell adhesive CBP induced a 2.2‐fold increase in cell spreading, compared to pristine cellulose. The study was published in the July 2020 issue of Advanced Healthcare Materials.

“In bacterial cultures, over 99.99% of the germs were killed by the peptide-containing membranes. In future, the antimicrobial membranes will be equipped with additional functions,” said co-senior author Katharina Maniura-Weber, PhD, of the Empa Biointerfaces lab. “The peptides might, for instance, be functionalized with binding sites that enable the controlled release of further therapeutic substances.”

AMPs are potent, broad spectrum therapeutic agents that have been shown to kill both Gram positive and gram negative bacteria, enveloped viruses, fungi, and even some cancerous cells. Unlike antibiotic drugs, AMPs appears to destabilize biological membranes, can form transmembrane channels, and may have the ability to function as immunomodulators by altering host gene expression, inducing chemokine production, promoting wound healing, and modulating the responses of dendritic cells and cells of the adaptive immune response.

Related Links:

Swiss Federal Laboratories for Materials Science and Technology


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Medical Examination & Procedure Light
Vega 80
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.